Mitsubishi UFJ Asset Management Co. Ltd. Grows Stock Holdings in Omnicell, Inc. $OMCL

Mitsubishi UFJ Asset Management Co. Ltd. increased its position in shares of Omnicell, Inc. (NASDAQ:OMCL) by 38.6% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 21,949 shares of the company’s stock after purchasing an additional 6,117 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd.’s holdings in Omnicell were worth $645,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Pacer Advisors Inc. purchased a new stake in Omnicell during the 1st quarter worth about $10,542,000. Nuveen LLC acquired a new stake in shares of Omnicell during the 1st quarter worth about $6,218,000. Wellington Management Group LLP raised its position in shares of Omnicell by 52.6% during the 1st quarter. Wellington Management Group LLP now owns 496,680 shares of the company’s stock worth $17,364,000 after acquiring an additional 171,116 shares in the last quarter. Strs Ohio purchased a new stake in Omnicell during the first quarter worth approximately $5,635,000. Finally, Victory Capital Management Inc. boosted its holdings in Omnicell by 10.1% in the first quarter. Victory Capital Management Inc. now owns 1,680,347 shares of the company’s stock valued at $58,745,000 after purchasing an additional 154,038 shares in the last quarter. 97.70% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

OMCL has been the topic of several recent analyst reports. Piper Sandler dropped their price target on shares of Omnicell from $57.00 to $55.00 and set an “overweight” rating on the stock in a research note on Monday, August 11th. Wall Street Zen cut shares of Omnicell from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 9th. Wells Fargo & Company lifted their price target on shares of Omnicell from $37.00 to $40.00 and gave the stock an “overweight” rating in a research note on Monday, July 21st. Weiss Ratings reissued a “sell (d+)” rating on shares of Omnicell in a research report on Wednesday, October 8th. Finally, Benchmark upped their price objective on shares of Omnicell from $40.00 to $45.00 and gave the company a “buy” rating in a research note on Friday, October 31st. Three research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $42.00.

Insider Activity at Omnicell

In other news, EVP Corey J. Manley sold 3,880 shares of the stock in a transaction dated Friday, September 12th. The shares were sold at an average price of $33.25, for a total transaction of $129,010.00. Following the completion of the sale, the executive vice president owned 110,653 shares in the company, valued at approximately $3,679,212.25. This represents a 3.39% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 2.52% of the company’s stock.

Omnicell Stock Down 1.2%

OMCL stock opened at $35.12 on Friday. The company has a market cap of $1.58 billion, a price-to-earnings ratio of 70.24, a price-to-earnings-growth ratio of 6.29 and a beta of 0.95. The company has a fifty day moving average price of $31.94 and a 200 day moving average price of $30.54. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.42 and a quick ratio of 1.24. Omnicell, Inc. has a 12 month low of $22.66 and a 12 month high of $48.67.

Omnicell Company Profile

Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.